AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31597550 — intervention group
Group type: COMPARATOR
Intervention: Total ischemic stroke
Number of subjects: 446696
Study 31597550 — intervention group
Group type: COMPARATOR
Intervention: Cardioembolic stroke
Number of subjects: 446696
Study 30295684 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (rTMS at point -40; 48; 35)
Number of subjects: 46
Study 30295684 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (rTMS at point -46; 45; 38)
Number of subjects: 46
Study 30295684 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (rTMS at point -38; 44; 26)
Number of subjects: 46
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients during the ANBP2 clinical trial
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients during post-trial follow-up
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall hypertensive patients
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly hypertensive patients with various characteristics
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly hypertensive patients with diabetes and smoking
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly hypertensive patients with higher systolic blood pressure
Number of subjects: 6083
Study 26508441 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly hypertensive patients diagnosed with HF
Number of subjects: 6083
Study 24729398 — intervention group
Group type: EXPERIMENTAL
Intervention: golimumab 50 mg from weeks 0 to 48
Number of subjects: 213
Study 24729398 — intervention group
Group type: COMPARATOR
Intervention: placebo from weeks 0 to 20 followed by golimumab 50 mg from weeks 24 to 48
Number of subjects: 213
Study 22581157 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy
Number of subjects: 0
Study 22581157 — intervention group
Group type: COMPARATOR
Intervention: General psychiatric management
Number of subjects: 0
Study 20858280 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (anthelmintic treatment)
Number of subjects: 320
Study 20858280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 19378443 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help intervention with five communication sheets
Number of subjects: 1201
Study 16819768 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 2.5 mg and molsidomine 1 mg
Number of subjects: 1219
Study 16819768 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 2.5 mg
Number of subjects: 1219
Study 16819768 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 5 mg
Number of subjects: 1219
Study 16819768 — intervention group
Group type: EXPERIMENTAL
Intervention: molsidomine 1 mg
Number of subjects: 1219
Study 16819768 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1219
Study 12814763 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (500 mg of elemental calcium as carbonate and 400 IU of vitamin D bid for 12 months)
Number of subjects: 192
Study 12814763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 12814763 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 192
Study 10658002 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids and carbohydrate drink (6 g essential amino acids, 35 g sucrose)
Number of subjects: 6
Study 10658002 — intervention group
Group type: COMPARATOR
Intervention: Flavored placebo drink
Number of subjects: 6
Study 9298338 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG at tender points along the palpated myofascial band
Number of subjects: 164
Study 9298338 — intervention group
Group type: COMPARATOR
Intervention: EMG at a nonselected site
Number of subjects: 164
Study 8138866 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind, placebo‐controlled medication trial (MT)
Number of subjects: 24
Study 8138866 — intervention group
Group type: COMPARATOR
Intervention: Typical clinical procedures (TCP) evaluation
Number of subjects: 24
Study 8138866 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MT and TCP conditions
Number of subjects: 24
Study 2875674 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 0
Study 2875674 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 0
Study 2875674 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study 30579511 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined transoral sialolitectomy (CTS)
Number of subjects: 22
Study 30579511 — intervention group
Group type: COMPARATOR
Intervention: Open submaxillectomy
Number of subjects: 22
Study 29523719 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-high STI risk perception
Number of subjects: 0
Study 29523719 — intervention group
Group type: EXPERIMENTAL
Intervention: New sexual partners in the last 6 months (≥3 partners)
Number of subjects: 0
Study 29523719 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of condom use among women with a new partner in the last 6 months
Number of subjects: 0
Study 29523719 — intervention group
Group type: EXPERIMENTAL
Intervention: Genital warts in the last year, binge drinking, and being single
Number of subjects: 0
Study 26649604 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cochlear implantation
Number of subjects: 38
Study 26649604 — intervention group
Group type: COMPARATOR
Intervention: Unilateral cochlear implantation
Number of subjects: 38
Study 24464258 — intervention group
Group type: COMPARATOR
Intervention: PAIR without albendazole (Group 1)
Number of subjects: 39
Study 24464258 — intervention group
Group type: EXPERIMENTAL
Intervention: PAIR with albendazole 1 week before and 1 month after (Group 2)
Number of subjects: 39
Study 24464258 — intervention group
Group type: EXPERIMENTAL
Intervention: PAIR with albendazole 1 week before and 3 months after (Group 3)
Number of subjects: 39
Study 22370767 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer surgery
Number of subjects: 0
Study 22370767 — intervention group
Group type: COMPARATOR
Intervention: Elective coronary artery stenting
Number of subjects: 0
Study 19716319 — intervention group
Group type: EXPERIMENTAL
Intervention: Epalrestat 150 mg/day (EP group)
Number of subjects: 38
Study 19716319 — intervention group
Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 38
Study 17925428 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol group (group A)
Number of subjects: 135
Study 17925428 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 135
Study 15808118 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 250 microg/day for 4 weeks
Number of subjects: 22
Study 15808118 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg/day orally for 4 weeks
Number of subjects: 22
Study 11950766 — intervention group
Group type: EXPERIMENTAL
Intervention: Monozygotic twins
Number of subjects: 0
Study 11950766 — intervention group
Group type: COMPARATOR
Intervention: Matched control sample
Number of subjects: 0
Study 8173242 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT work (less than 6 hours daily)
Number of subjects: 102
Study 8173242 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT work (more than 6 hours daily)
Number of subjects: 102
Study 8173242 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT workers
Number of subjects: 102
Study 8173242 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular VDT workers (n = 3)
Number of subjects: 102
Study 3555513 — intervention group
Group type: EXPERIMENTAL
Intervention: Bardac-22 (didecyl-dimethyl-ammonium chloride) in combination with prednicarbate
Number of subjects: 0
Study 3555513 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31544524 — intervention group
Group type: EXPERIMENTAL
Intervention: Abductor muscle strengthening rehabilitation program (extra 2-week rehabilitation after standard early postoperative rehabilitation)
Number of subjects: 103
Study 31544524 — intervention group
Group type: COMPARATOR
Intervention: Standard early postoperative rehabilitation
Number of subjects: 103
Study 30820772 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training plus photobiomodulation
Number of subjects: 45
Study 30820772 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training plus placebo
Number of subjects: 45
Study 30820772 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training or photobiomodulation)
Number of subjects: 45
Study 27573881 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation
Number of subjects: 17
Study 27573881 — intervention group
Group type: COMPARATOR
Intervention: Non-toric intraocular lens (IOL) implantation
Number of subjects: 17
Study 23702221 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel, small-group sexual assault resistance education program (4 units, 12 hours total)
Number of subjects: 1716
Study 23702221 — intervention group
Group type: COMPARATOR
Intervention: Current university practice of providing informational brochures
Number of subjects: 1716
Study 21935847 — intervention group
Group type: EXPERIMENTAL
Intervention: Abductor Pollicis Longus (APL) tendon technique
Number of subjects: 53
Study 21935847 — intervention group
Group type: COMPARATOR
Intervention: Flexor Carpi Radialis (FCR) tendon technique
Number of subjects: 53
Study 19687490 — intervention group
Group type: EXPERIMENTAL
Intervention: TwHF extract, 60 mg 3 times daily
Number of subjects: 121
Study 19687490 — intervention group
Group type: COMPARATOR
Intervention: sulfasalazine, 1 g twice daily
Number of subjects: 121
Study 19687490 — intervention group
Group type: EXPERIMENTAL
Intervention: TwHF extract
Number of subjects: 121
Study 19687490 — intervention group
Group type: COMPARATOR
Intervention: TwHF extract and sulfasalazine
Number of subjects: 121
Study 16961789 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 50
Study 16961789 — intervention group
Group type: COMPARATOR
Intervention: Control (migrainous children without FGIDs)
Number of subjects: 50
Study 14968053 — intervention group
Group type: EXPERIMENTAL
Intervention: Teenage pregnancy and delivery
Number of subjects: 276
Study 14968053 — intervention group
Group type: COMPARATOR
Intervention: Control group (300 women aged more than 18 years)
Number of subjects: 276
Study 11527646 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 8 weeks
Number of subjects: 16
Study 9250803 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR analyses for HHV‐8 detection
Number of subjects: 19
Study 9250803 — intervention group
Group type: EXPERIMENTAL
Intervention: Samples containing the EBV genome
Number of subjects: 19
Study 8325046 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day of oral sulodexide (enteric-coated tablets)
Number of subjects: 16
Study 8325046 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day of oral sulodexide (enteric-coated tablets)
Number of subjects: 16
Study 8325046 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated administration of sulodexide (100 mg/day and 200 mg/day)
Number of subjects: 16
Study 8325046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8325046 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide (oral administration)
Number of subjects: 16
Study 3062042 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 169
Study 3062042 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 169
Study 30439760 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (200 mL daily with Lactobacillus acidophilus La‐5, Bifidobacterium animalis subsp. lactis Bb‐12, Lactobacillus casei subsp. casei Lc‐01)
Number of subjects: 314
Study 30439760 — intervention group
Group type: COMPARATOR
Intervention: Placebo yogurt (200 mL daily with Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus)
Number of subjects: 314
Study 30439760 — intervention group
Group type: COMPARATOR
Intervention: Unblinded control (no yogurt)
Number of subjects: 314
Study 30439760 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined blinded study groups (probiotic and placebo)
Number of subjects: 314
Study 30439760 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 314
Study 28792997 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 440
Study 28792997 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 440
Study 28792997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study 25729066 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (combined superficial and perforating vein surgery)
Number of subjects: 196
Study 25729066 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory compression therapy
Number of subjects: 196
Study 23995464 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulated, home-based exercise program
Number of subjects: 11
Study 20110162 — intervention group
Group type: EXPERIMENTAL
Intervention: Field in field (FIF) technique
Number of subjects: 12
Study 20110162 — intervention group
Group type: EXPERIMENTAL
Intervention: Non field in field - normalization to isodose line (NFIF-I)
Number of subjects: 12
Study 20110162 — intervention group
Group type: EXPERIMENTAL
Intervention: Non field in field - normalization to target volume (NFIF-V)
Number of subjects: 12
Study 19327948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40
Study 19327948 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 40
Study 18220219 — intervention group
Group type: EXPERIMENTAL
Intervention: Biolight therapy
Number of subjects: 60
Study 18220219 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 60
Study 15292326 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy for 6 months
Number of subjects: 18
Study 15292326 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and body mass index-matched premenopausal women; n=20)
Number of subjects: 18
Study 15292326 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate-induced vasodilation
Number of subjects: 18
Study 11562652 — intervention group
Group type: EXPERIMENTAL
Intervention: New radiographic measurement method for axial rotation (Ry)
Number of subjects: 3
Study 11562652 — intervention group
Group type: EXPERIMENTAL
Intervention: New radiographic measurement method for lateral bending (Rz)
Number of subjects: 3
Study 11562652 — intervention group
Group type: EXPERIMENTAL
Intervention: New axial rotation method applied to a C3 plastic model
Number of subjects: 3
Study 9065293 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiographic (ECG) technique
Number of subjects: 1822
Study 9065293 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy technique
Number of subjects: 1822
Study 8202242 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by military nurses (9 visits over 3 months)
Number of subjects: 75
Study 8202242 — intervention group
Group type: COMPARATOR
Intervention: Control group (no home visits)
Number of subjects: 75
Study 3310625 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 258
Study 3310625 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g four times daily
Number of subjects: 258
Study 3310625 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 258
Study 30646266 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Healthy Living Program (intervention group)
Number of subjects: 8371
Study 28340625 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit training with computer-assisted direct visual biofeedback (HTBF)
Number of subjects: 394
Study 28340625 — intervention group
Group type: COMPARATOR
Intervention: Habit training (HT)
Number of subjects: 394
Study 28340625 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigation-led allocation (INVEST) to either HT or HTBF
Number of subjects: 394
Study 28340625 — intervention group
Group type: COMPARATOR
Intervention: No-investigation allocation (No-INVEST)
Number of subjects: 394
Study 26132393 — intervention group
Group type: EXPERIMENTAL
Intervention: pravastatin 40mg
Number of subjects: 1016
Study 26132393 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 20mg
Number of subjects: 1016
Study 26132393 — intervention group
Group type: COMPARATOR
Intervention: statins (combined)
Number of subjects: 1016
Study 26132393 — intervention group
Group type: EXPERIMENTAL
Intervention: statins (especially simvastatin)
Number of subjects: 1016
Study 26132393 — intervention group
Group type: EXPERIMENTAL
Intervention: statins (in postmenopausal women)
Number of subjects: 1016
Study 26132393 — intervention group
Group type: EXPERIMENTAL
Intervention: statins (in postmenopausal women aged ≥45)
Number of subjects: 1016
Study 26132393 — intervention group
Group type: EXPERIMENTAL
Intervention: statins (in women with low baseline aggression)
Number of subjects: 1016
Study 23967083 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% DEET lotion
Number of subjects: 7979
Study 23967083 — intervention group
Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 7979
Study 21679156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin (10 ml)
Number of subjects: 197
Study 21679156 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg)
Number of subjects: 197
Study 21679156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Cerebrolysin and Donepezil
Number of subjects: 197
Study 21679156 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 197
Study 19480294 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 0
Study 16603032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) plus medication (fluvoxamine)
Number of subjects: 48
Study 16603032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 48
Study 16603032 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication (fluvoxamine)
Number of subjects: 48
Study 16603032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 14675083 — intervention group
Group type: EXPERIMENTAL
Intervention: melagatran/ximelagatran
Number of subjects: 2835
Study 14675083 — intervention group
Group type: COMPARATOR
Intervention: enoxaparin
Number of subjects: 2835
Study 10832254 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam restorations with adhesive liner
Number of subjects: 0
Study 10832254 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restorations with copal varnish and zinc phosphate cement
Number of subjects: 0
Study 8876403 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention programme involving a new approach to decision-making concerning long-term care of dependent elderly patients, including an early discharge planning service and an extended home care programme.
Number of subjects: 0
Study 8876403 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention programme involving a new approach to decision-making concerning long-term care of dependent elderly patients.
Number of subjects: 0
Study 1291393 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin bonding resin groups
Number of subjects: 100
Study 1291393 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer‐based restorations
Number of subjects: 100
Study 1291393 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based bonding systems
Number of subjects: 100
Study 12267101 — intervention group
Group type: EXPERIMENTAL
Intervention: Venotonic
Number of subjects: 40
Study 12267101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31533551 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with VTE
Number of subjects: 331950
Study 29437981 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation hydrogel coils
Number of subjects: 484
Study 29437981 — intervention group
Group type: COMPARATOR
Intervention: Bare platinum coils (Control)
Number of subjects: 484
Study 26608333 — intervention group
Group type: EXPERIMENTAL
Intervention: Get Busy Get Better (GBGB) intervention
Number of subjects: 208
Study 26608333 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed intervention)
Number of subjects: 208
Study 24880753 — intervention group
Group type: EXPERIMENTAL
Intervention: Almorexant 200mg
Number of subjects: 20
Study 24880753 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine 50mg
Number of subjects: 20
Study 24880753 — intervention group
Group type: EXPERIMENTAL
Intervention: Almorexant 200mg + Desipramine 50mg
Number of subjects: 20
Study 24880753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) - 1 g loading dose infused over 10 minutes followed by 1 g intravenous infusion over 8 hours
Number of subjects: 270
Study 22417901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 22417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 270
Study 21058191 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose isoflavone supplement (450 mg genistein, 300 mg daidzein) daily for 6 months
Number of subjects: 53
Study 17558828 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic testing consent process
Number of subjects: 755
Study 17558828 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who consented to genetic analysis
Number of subjects: 755
Study 15090073 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-week relaxation response intervention
Number of subjects: 134
Study 11212979 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide SR 1.5 mg
Number of subjects: 524
Study 11212979 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 524
Study 11212979 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 524